Survival of patients with pancreatic cancer is poor. Adenoviral (Ad) gene therapy employing the commonly used serotype 5 reveals limited transduction efficiency due to the low amount of coxsackie-adenovirus receptor on pancreatic cancer cells. To identify fiber-chimeric adenoviruses with improved gene transfer, a library of Ad vectors based on Ad5 and carrying fiber molecules consisting of 16 other serotypes were transduced to human pancreatic carcinoma cell lines. Adenoviruses containing fibers from serotype 16 and 50 showed increased gene transfer and were further analyzed. In a gene-directed prodrug activation system using cytosine deaminase, these adenoviruses proved to be effective in eradicating primary pancreatic tumor cells. Fiber-chimeric Ad5 containing fiber 16 and wild-type Ad5 were also transduced ex vivo to slices of normal human pancreatic tissue and pancreatic carcinoma tissue obtained during surgery. It was shown that fiber-chimeric Ad5 with fiber 16 revealed an improved gene delivery to primary pancreatic tumor tissue compared to Ad5. In conclusion, fiber-chimeric adenoviruses carrying fiber 16 and 50 reveal a significantly enhanced gene transfer and an increased specificity to human pancreatic adenocarcinoma compared to Ad5, whereas transduction to normal pancreatic tissue was decreased. These findings expand the therapeutic window of Ad gene therapy for pancreatic cancer.
Introduction
Pancreatic cancer is a major health problem. It is the fourth leading cause of cancer death in the Western world, and the overall 5-year survival rate of 3-5% has not changed over the past 25 years. 1 Because of the late onset of symptoms, only 15-20% of patients are eligible for pancreatic resection with a curative intention. The 5-year survival of these patients who are treated most optimally is only 17%. 2 Many different radio-or chemotherapy regimens have been tested in clinical trials, but only few of these regimens proved to prolong survival. 3 These data indicate that novel therapeutic modalities, such as gene therapy, must be developed. Adenoviral (Ad) vectors are widely used as delivery vehicles for gene therapy. These nonenveloped double-stranded DNA viruses are stable and can be propagated to high titers (up to 10 13 viral particles (VP) per ml), do not integrate into host DNA and are able to infect both quiescent and replicating target cells. Adenoviruses that selectively replicate in and kill tumor cells seem promising. Conditionally replicative adenovirus (CRAd) uses differences in cell-cycle control between tumor cells and normal cells to replicate selectively in tumor tissue. 4, 5 Ad vectors have an icosahedral capsid with 12 protruding knobbed fibers. The fibers and fiber knobs bind to receptors on the target cell and, as such, determine the tropism of the virus for a certain cell type. Adenovirus serotype 5 (Ad5) has been used most frequently in human clinical gene therapy trials. Target cell entry of Ad5 starts with the binding of the fiber to the coxsackie-adenovirus receptor (CAR). 6 However, pancreatic adenocarcinoma as well as many other malignancies display very low levels of CAR, making Ad5 less suitable for cancer gene therapy. 7, 8 This CAR deficiency may hamper efficacious lateral spread of the CRAd ONYX-015 upon injection in pancreatic cancer. 9, 10 Fibers of other Ad serotypes bind to other receptors, some of which may be highly expressed on pancreatic cancer cells. Therefore, fiber-chimeric adenoviruses in which the tropism is determined by the fiber of an alternative Ad serotype may enhance Ad entry into pancreatic cancer cells. 11, 12 The backbone of Ad5 was used to ascertain the reproducible production of high titers. At present, 51 distinct serotypes have been recognized. They are divided into six subgenera (A-F) and subclassifications (BI-II and DI-III) according to their genome size, organization and homology, hemagglutination properties and oncogenicity (Table 1) . 13 Furthermore, the serotypes differ with respect to their natural target tissue. For instance, serotype 40 and 41 display a tropism for intestinal epithelium, whereas serotype 4 displays tropism to the respiratory tract and the eye.
The aim of this study was to identify fiber-chimeric adenoviruses with improved gene transfer to pancreatic cancer cells. Therefore, near primary human pancreatic adenocarcinoma cells were infected with a library of these chimeric adenoviruses. In addition to enhanced entry of pancreatic cancer cells, lower affinity for human hepatocytes is beneficial because of the hepatotropism of adenovirus, especially of Ad5. Therefore, the chimeric Ad vectors were also tested on primary human hepatocytes. Those chimeric viral vectors (that is, Ad5 containing fiber 16 or 50) that displayed improved transduction of pancreatic cancer cells or increased specificity compared to Ad5 were subsequently tested on normal human pancreatic cells and pancreatic adenocarcinoma specimens derived from patients. Furthermore, fiber-chimeric adenoviruses expressing cytosine deaminase (CD) were constructed to test their efficacy in a gene-directed prodrug activation system.
Materials and methods
Fiber amplification and generation of fiber-chimeric viruses Human wild-type adenoviruses were propagated on PER.C6 cells, 14 and viral DNA was isolated as described previously. 15 Fiber genes were PCR amplified with distinct sets of 'subgroup-specific' oligonucleotides, as described by Havenga et al. 12 Subsequently, fiber sequences were cloned in an NdeI-and NsiI-digested pBr/Ad.BamRDFIB plasmid, thus generating a library of plasmids coded pBr/Ad.BamRDFIBXX, where 'XX' represents the serotype from which the fiber was amplified. Plasmid pBr/Ad.BamRDFIB has been described previously. 16 To generate recombinant adenovirus, two DNA molecules were cotransfected on PER.C6 cells: (1) pWE/Ad.AflII-rITR/FibXX linearized with PacI and (2) a plasmid encoding the Ad5 sequence, in which the E1 region is replaced by a marker gene.
This plasmid (pAdapt) contains the Ad5 sequence from nt 1 to 454 (left ITR and packaging signal), a cassette for transgene expression containing the cytomegalovirus (CMV) promoter nt 735 to 95 [pAdapt]), a polylinker, Simian virus 40 (SV40) intron-poly (A) from pcDNA1 (HhaI-AvrII fragment; Invitrogen, Breda, The Netherlands) and a second Ad5 sequence ranging from nt 3511 to 6095. pAdapt lacks the SV40 intron sequences. The Ad5 sequence (nt 3511 to 6095) enables the generation of recombinant adenovirus through homologous recombination with pWE/Ad.AflII-rITR/FibXX on PER.C6 cells.
The following genes were cloned into the deleted E1 region of Ad5: the luciferase (luc) gene (driven by the weak CMV promoter pClip), the green fluorescent protein (GFP) gene, the DsRed marker gene (derived from pDsRed1-N1, Clontech, Palo Alto, CA) and the Escherichia coli CD gene (a gift from Dr C Mullen 17 ), as described. 18 The latter three genes were each driven by the standard CMV promoter (pAdapt).
Generation and purification of recombinant adenovirus
The generation and purification of fiber-chimeric Ad vectors on PER.C6 cells have been described previously. 11, 16 Briefly, virus produced on four T175 triplelayer tissue culture flasks was purified with a two-step cesium chloride purification protocol. After purification, virus was stored in aliquots at À80 1C. The virus titer expressed in VP per ml was determined by high-pressure liquid chromatography. 18 Plaque purifications and end point titrations were performed as described previously. 14, 19 Ad5.F5.CD, Ad5.F16.CD and Ad5.F50.CD viruses were produced on ten 150-mm plates. Crude cell lysates were titrated using standard plaque assay analyzing plaque-forming units (PFU). The production yields of 8 PFU per ml. Additional virus batches were used for infection of patient-derived specimens. The number of genomic copies (gc) was determined by quantitative real-time PCR by using the primers against hexon DNA (forward: gacatgactttcgagctcgatcccatgga, reverse ccggccgagaagggtgtgcgcaggta. 20 The production yields of the viral batches (in gc per ml) were as follows: Ad5. GFP 21 Hepatocytes were cultured in Williams' E medium supplemented with 4% (v/v) heat-inactivated fetal bovine serum, 2 mM L-glutamine, 1 mM dexamethasone, 20 mU ml À1 insulin, 2 mM ornithine and penicillin/streptomycin/fungizone mix. All cells were cultured at 37 1C in 10% CO 2 atmosphere.
Luciferase assay
To assess the infection efficiency of the different fiberchimeric adenoviruses in our library, 5 Â 10 4 cells were plated in 24-well plates and allowed to adhere overnight. Cells were infected at a multiplicity of infection (MOI) of 100 and 1000 VP per cell for 1 h at 37 1C. The virus was removed and cells were incubated in complete media. To assess luciferase expression, cell lysates were assayed 48 h after infection using a luciferase assay system (Promega, Madison, WI) and a Berthold luminometer (Promega), and the protein concentration was determined using the Pierce Protein Assay according to the manufacturer's protocols, using bovine serum albumin as standard.
PCR analysis of fiber genes
Fiber knob domains were PCR amplified to detect any contamination during virus production and purification of the fiber-chimeric adenoviruses of interest: Ad5.Fib5, Ad5.Fib16 and Ad5.Fib50. The following fiber-specific primers were used: fiber5-forward 5
Flow cytometry GFP expression was analyzed 48 h after infection at an MOI of 100 and 1000 VP per cell. Cells were released with cell dissociation buffer (Gibco BRL Life Technologies), quenched with DMEM containing 10% fetal bovine serum and pelleted. Cells were washed in cold phosphatebuffered saline (PBS), fixated in 2% paraformaldehyde in PBS and counted by flow cytometry (FACScalibur; Becton, Dickinson and Company, Franklin Lakes, NJ). Data were expressed as the geometric mean fluorescence intensity of the entire gated population. The positive cell population was determined by gating the right-hand tail of the distribution of the negative control sample for each individual cell line at 0.1%. This gate setting was then used to determine the percentage of GFP-positive cells in each individual cell line.
Knob 5 blocking experiment
To confirm CAR-independent entry of the fiber-chimeric adenoviruses, soluble Ad fiber knob 5 was produced to perform blocking experiments. The plasmid that was used to produce soluble fiber knob was kindly provided by Dr J Douglas, University of Alabama, Birmingham. Soluble knob 5 was produced by expression in E. coli with Nterminal His6 tags, using the pQE30 expression vector (Qiagen, Hilden, Germany). 22 Recombinant proteins were purified on Ni-nitrilotriacetic acid agarose columns. The ability of the knob 5 protein to form homotrimers was verified by SDS-polyacrylamide gel electrophoresis of boiled and unboiled samples. The concentration of the purified knob was determined using the Pierce Protein Assay.
Cells were plated in a 48-well culture plate (5 Â 10 4 cells per well) and allowed to adhere overnight. Cells were incubated at room temperature for 45 min with 10 pg per well knob 5 in a total volume of 100 ml PBS before infection. Subsequently, virus was added in 100 ml DMEM/4% fetal calf serum (FCS). One hour after virus addition the medium was aspired and fresh complete medium was added. After 48 h GFP expression was analyzed by flow cytometry.
WST-1 assay
Constructs with the CD/5-fluorocytosine (5-FC) genedirected prodrug activation system were generated from the fiber-chimeric adenoviruses that displayed enhanced entry of pancreatic cancer cells to allow additional studies of an antitumor effect, needed for in vivo use. CDexpressing cells can be killed by treatment with a nontoxic prodrug 5-FC, which is converted into the highly toxic chemotherapeutic agent 5-fluorouracil by CD.
Cells were plated in 96-well culture plates at 5 Â 10 viruses at an MOI of 1, 10 and 100 PFU per cell in DMEM. Ad5-Fib5-GFP was used as a CD-negative control. After 2 h of infection 200 ml complete media was added. At day 3 and 5, medium was removed and fresh complete medium with or without 1.2 mM 5-FC was added (Sigma-Aldrich, Zwijndrecht, the Netherlands). At day 6, cells were washed with PBS and 10 ml per well of the cell proliferation reagent WST-1 (Boehringer Mannheim, Mannheim, Germany) was added in a total volume of 100 ml medium. Absorbance of the samples was analyzed using a bichromatic enzyme-linked immunosorbent assay reader. WST conversion is measured as the OD 450-650 nm, to correct for absorption by the medium. 5 cells per slice based on a 10-cell-thick slice (250 mm) and 4 mm slice diameter, thus the VP per cell ratio was approximately 400. Plates were placed in a plastic container that was gassed with 95% O 2 and continuously shaken back and forth (100 times per min) as described previously. 23 The container and shaker were placed in a humidified incubator at 37 1C.
Slices were removed from culture after 72 h and stored overnight at 4 1C in radioimmunoprecipitation assay lysis buffer (25 mM Tris-HCl (pH 7.6), 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS). The next day virus-infected slices were freeze-thawed once and total fluorescence of GFP and dsRED was measured with a NOVOstar fluorometer (BMG Labtechnologies, Offenburg, Germany).
Results

Transduction of fiber-chimeric adenoviruses to pancreatic cancer cell lines
To obtain an overview of the infectivity rates, a panel of 16 fiber-chimeric adenoviruses representing all subgroups of human Adenoviridae was tested on four established cell lines (BxPc-3, Capan-1, Hs766-T and MIA PaCa-2) and two near primary cell lines (p6.3 and p10.5). In established as well as primary cell lines, fiber-chimeric viruses expressing fibers from subgroup B showed the highest luciferase transgene expression (Figure 1a) . Cell lines BxPc-3 and MIA PaCa-2 had similar results (not shown). In all cell lines, transgene expression of chimeric viruses expressing fibers of Ad16 and Ad50 was 10-to 30-fold increased compared to the unmodified Ad5. Transgene expression from chimeric adenoviruses with fibers from subgroups A, D and F-G was comparable or even lower than Ad5. Figure 1b revealed transgene expression in primary hepatocytes upon infection with these fiberchimeric adenoviruses. Because the number of human primary hepatocytes from a single isolation is limited, infections were performed with an MOI of 1000 only. In these human primary hepatocytes, infection with wildtype Ad5 resulted in the highest transgene expression, confirming the hepatotropism of this virus. Ad5.Fib16.Luc and A5.Fib50.Luc showed a 70-to 100-fold decreased expression of luciferase in these hepatocytes compared to wild-type Ad5.
Analysis of DNA of various fiber-chimeric adenoviral batches to rule out cross-contamination Because Ad5.Fib16 and Ad5.Fib50 showed efficient transduction to pancreatic cancer cells with a reduced infection of human primary hepatocytes, both were selected for further analysis. In addition to the viruses expressing luciferase, viruses were generated that expressed GFP and the E. coli CD gene. We performed a fiber-specific PCR to ensure that no cross-contamination with these recombinant viruses had occurred. Figure 2 shows that different viral batches reveal only a fiberspecific PCR product after DNA electrophoresis of their cloned recombinant fiber, confirming the correct recombinant viruses. These viral batches were used for subsequent studies. We chose to use the two near primary pancreatic cancer cell lines instead of the four established cell lines because they are more comparable to human pancreatic adenocarcinoma.
Flow cytometry of fiber-chimeric adenoviruses expressing GFP in the presence and absence of Ad5 fiber protein To ensure that the increased transgene expression was due to transduction of a higher percentage of cells with Ad5.Fib16.Luc and Ad5.Fib50.Luc, we generated viruses expressing GFP. Figure 3 shows the fluorescent microscope picture and the corresponding flow cytofluorometric analysis upon infection with Ad5.GFP, Ad5.Fib16.GFP and Ad5.Fib50.GFP of human near primary pancreatic cancer cell lines p6.3 and p10.5. When Figure 1 Transduction of human pancreatic cancer cell lines and primary human hepatocytes by fiber-chimeric adenovirus. Upon plating and O/ N adherence, the cells were incubated for 1 h with 100 (MOI 100) or 1000 (MOI 1000) viral particles per cell. After washing fresh medium was added and 48 h after infection the cells were lysed and luciferase activity was determined Luciferase activity, expressed as relative light units (RLU) per mg of total cellular protein, in (a) established (Capan-1 and Hs766-T) and primary (p6.3 and p10.5) pancreatic adenocarcinoma cells, in (b) primary isolated hepatocytes at 48 h after exposure to a panel of fiber-chimeric adenoviruses. Values represent the mean±standard deviation.
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As shown in Figure 3 , addition of 10 pg per well of Ad5 knob blocked the transduction by Ad5.GFP. The transduction percentage seen in cell line p6.3 was reduced from 26.6 to 7.8% and from 56.2 to 14.6% in cell line p10.5. This amount of soluble knob 5 did not affect the transduction by Ad5.Fib16.GFP and Ad5.Fib50.GFP, confirming that both fiber 16 and fiber 50 indeed use an alternative cell entry pathway.
Improved cell-kill of pancreatic tumor cells by Ad5.Fib16 and Ad5.Fib50 expressing the cytosine deaminase gene To assess if the increase in transduction efficiency in pancreatic cancer cells obtained is sufficient to enhance the cytotoxic potential of the fiber-chimeric Ad vectors, we tested them in a suicide gene approach. To add cytotoxic capacity we introduced the bacterial CD/5-FC gene-directed prodrug activation system to the chimeric adenoviruses. To assess the efficacy of the fiber-chimeric adenoviruses in this system, we infected pancreatic cancer cells with Ad5.bCD, Ad5.Fib16.bCD and Ad5.-Fib50.bCD at an MOI of 0, 1, 10 and 100. Five days after viral infection and repeated administrations of 5-FC, the cytotoxic effect was determined by measuring mitochondrial activity using the WST-1 assay. In both p6.3 and p10.5 pancreatic cancer cells, a significant lower WST-1 conversion is seen upon infection with Ad5.-Fib16.bCD and Ad5.Fib50.bCD, whereas upon infection with Ad5.bCD the effect of WST-1 conversion is minimal (Figure 4) . This difference in WST-1 conversion indicates that in this suicide gene approach both chimeric Ad vectors are more effective to kill pancreatic tumor cells than the vector with the Ad5 fiber. Also in established pancreatic cancer cell lines, Ad5.bCD appeared to have a less efficient gene transfer than Ad5.Fib16.bCD and Ad5.F50.bCD (data not shown). Thus, in these in vitro studies both chimeric Ad vectors demonstrate increased efficacy to treat human pancreatic cancer.
Ad5.Fib16 revealed enhanced transduction of tissue slices derived from human pancreatic adenocarcinoma
Several studies have shown that preclinical studies in vitro and in animal models do not reliably predict the efficacy of Ad-mediated gene therapy obtained in a subsequent clinical trial. Therefore we decided to test the performance of the chimeric adenovectors in an ex vivo system using tissue slices derived from resection material. Tissue slices were cut from normal human pancreas and surgical resection specimens of patients with pancreatic cancer or other peripancreatic disease using a tissue slicer. These slices allow testing the transduction efficacy of our fiberchimeric advectors in a system that better resembles the clinical setting. In our tissue slice system, both normal tissue and cancer tissue can be cultured for at least 72 h without significant loss of viability (van Geer et al., in press). Because the amount of the available tissues was limited, we chose to analyze and compare Ad5.-Fib16.GFP versus Ad5.GFP. To be able to correct for differences in slice size, viability and composition we performed coinfection with an internal control (Ad5.dsRED). Tissue slices showing no transgene expression of GFP and dsRED were designated nonviable and were excluded. Next, we quantified reporter protein expression in pancreatic slices following infection with Ad5.Fib16.GFP and Ad5.GFP. To correct for differences in viability and composition between slices, in all experiments cotransduction with Ad5.dsRED was performed. The results are represented as the ratio of GFP/dsRED expression. As expected, because Ad5.GFP and Ad5.dsRED both have the same tropism, for Ad5 this ratio is close to 1. Because the tropism for Ad16 differs from that of Ad5, the GFP/ dsRED ratio will vary for this vector. A higher transduction efficiency of Ad16 will result in a ratio 41 and a lower efficiency will result in a ratio o1.
The ratios obtained in normal pancreatic tissue from four patients are presented in Figure 6a . In three experiments with normal pancreatic slices Ad16 showed lower GFP/dsRED ratio compared to Ad5: 2.3-(P ¼ 0.041), 2.8-(Po0.0001) and 1.3-fold (P ¼ 0.026) for N.2, N.3 and N.3, respectively. In the fourth experiment a similar transduction for Ad16 and Ad5 was observed (N.1, P ¼ 0.179). These data indicate that Ad5.GFP seems to have a higher affinity for normal pancreatic tissue than Ad5.Fib16.GFP.
In Figure 6b the ratios obtained with pancreatic cancer slices from four different patients are presented. In tumor 1, 2 and 4, the mean GFP/dsRED ratios of Ad5.-Fib16.GFP were 4.8-(P ¼ 0.010), 2.0-(P ¼ 0.040) and 2.3-fold (P ¼ 0.018) higher than ratios for Ad5.GFP. Also in tumor 3, a 4.3-fold increase in ratio was seen. However, this was not significant due to considerable variation Fiber-chimeric adenoviruses for pancreatic cancer KFD Kuhlmann et al between slices of this tumor. Thus in contrast to normal pancreas in tumor slices, the GFP/dsRED ratio for Ad16.GFP is higher than for Ad5.GFP.
The variation in transduction efficiency seen between tumor slices, which probably results from the cellular heterogeneity of pancreatic tumors, underscores . Coinfection with the same MOI of Ad5.dsRED was used as an internal control. After 36 h the medium was refreshed and at day 3 the slices were lysed and green fluorescent protein (GFP) and dsRED fluorescence was determined fluorometrically. Nontreated slices served as negative control. Typically, 4-10 slices were infected per viral vector. The fluorescence values per slice were used to calculate the GFP/dsRED ratio per slice and the mean values ± standard deviation (s.d.) of these ratios were calculated. The independent t-test was used to determine whether Ad5.Fib16.GFP transduction was significantly different ($, Po0.05) compared to Ad5.GFP.
Fiber-chimeric adenoviruses for pancreatic cancer KFD Kuhlmann et al the importance of cotransduction with an internal control.
In conclusion, these data indicate that Ad16 has a higher transduction efficiency in slices derived from pancreatic cancer than Ad5, whereas in slices from normal pancreatic transduction by Ad5 is more efficient.
Discussion
In most clinical trials the efficacy of Ad cancer gene therapy is disappointing, mostly due to very limited transduction. An important cause of the poor transduction efficiency in vivo seems to be the lack of sufficient expression of the primary receptor for adenovirus type 5 (CAR) on pancreatic cancer cells. Our ex vivo transduction data confirm this, because a fivefold higher dose of Ad5 was needed to obtain sufficient reporter gene expression in slices derived from tumor tissue compared to slices from normal pancreatic tissue.
Poor transduction by Ad5 is not unique for pancreatic cancer but a general problem since many malignancies (for example, ovarian, breast, bladder cancer) reveal low expression of CAR. [24] [25] [26] Different strategies can circumvent this problem. Pharmacological or chemical interventions can be performed to increase CAR expression and thus improve cell susceptibility to Ad infection. 27, 28 Other strategies are aimed at the circumvention of CAR deficiency by retargeting adenovirus to receptors that are present on these cancer cells, for instance by insertion of peptides into the HI loop of the fiber knob. We recently enhanced infectivity of pancreatic cancer by insertion of the Tyr-Ser-Ala peptide into the HI loop of the fiber knob, which targets the EphA2 receptor (van Geer et al., submitted). Another possibility is to exchange the fiber of Ad5, the serotype that is used in virtually all in vitro studies, in vivo studies and in clinical trials, with that of another serotype.
Studies have shown that the application of fiberchimeric adenoviruses, especially those containing subgroup B fibers, lead to an improved transduction in a variety of cell types, such as ovarian carcinoma, dendritic cells, cardiovascular tissue and intestinal mucosa. 11, 16, 25, 29 We recently improved transduction of esophageal cancer cells by using Ad5.Fib16 and Ad5.Fib50. 30 In contrast to the majority of Ad serotypes, those of subgroup B adenoviruses do not use the CAR receptor for cell attachment. The increased efficacy of subgroup B suggests that limited availability of CAR indeed is important in poor transduction of cancer cells by Ad5 vectors. The lack of blocking by soluble knob 5 protein shown in this study confirms that Ad5.Fib16 and Ad5.Fib50 bind to an alternative receptor. Complement regulatory protein CD46 has been shown to be a cellular receptor for subgroup B viruses. [31] [32] [33] [34] CD46 is highly expressed on many different tumor types including pancreatic cancer. The high expression of this receptor may offer a growth advantage to cancer cells by protecting them from complement damage. [35] [36] [37] [38] This increased expression on many different cancer types including pancreatic cancer renders CD46 an ideal target to obtain specific transduction of tumors. Here we showed that exchanging the fiber of Ad5 with fibers of serotype 16 and 50 indeed resulted in an enhanced gene transfer to human pancreatic adenocarcinoma cell lines. Our data are in accordance with another study in which chimeric Ad5 with fiber from serotype 35 (subgroup B) revealed enhanced gene transfer to pancreatic cancer cells. 39 In addition, we not only showed increased efficacy of these two chimeric viruses to near primary pancreatic cancer cells but also enhanced gene transfer of Ad5.Fib16 to human primary pancreatic (cancer) tissue specimens in our ex vivo tissue slice system. Increased efficacy in a system more comparable to the in vivo situation indicates that Ad5.Fib16 may be more effective in vivo as well. However, the magnitude of infectivity enhancement of 2-to 5-fold was modest.
The significant difference in targeting observed between established pancreatic cancer cell lines and tissue slices may be in part due to the heterogeneity of the slices. In contrast to in vitro cell cultures, that only contain pancreatic cancer cells, the slices will contain for example stromal cells. Specific targeting of tumor cells by Ad5.Fib16 therefore can be in part masked by a specific transduction of all other cells present in the specimen by Ad5. The heterogeneity of transduction of slices by Ad5 suggests that composition of the specimens may indeed differ significantly. We were not able to study this possibility because of the lack of truly specific markers for cancer cells and because we had only small amounts of tissue available, which did not allow us to make additional slides. Furthermore, not all pancreatic cancers are completely CAR deficient.
Immunohistochemical analysis of CAR expression on pancreatic cancer specimens showed high CAR levels on several cancers, predominantly on well-differentiated pancreatic tumors whereas poorly differentiated pancreatic tumors demonstrate loss or reduction of CAR expression. 40 Therefore different transduction percentages may also reflect differences in CAR expression in the pancreatic cancer cells of these slices. In addition, other receptors such as heparan sulfate proteoglycans (HSPGs) and integrins can also bind adenovirus type 5 and 2 with high affinity. 41 Overexpression of integrins and the HSPGs syndecan-1 and glypican-1 on pancreatic cancer will mediate transduction by Ad5 and will thus lower the effect of retargeting strategies. 7, 42, 43 However, because these proteins will also have an important function in vivo the targeting seen in these slices will reflect the efficacy of retargeting of this vector in patients.
The use of fiber-chimeric adenoviruses expands the therapeutic window of Ad gene therapy in pancreatic cancer. It enhances the gene transfer to pancreatic cancer cells compared to normal pancreatic tissue. In vivo data on tumor specificity of chimeric viruses are limited. Therefore we tried to look at potential in vivo targeting by infecting not only human pancreatic cancer explants, but also normal pancreatic tissue. Ad5.Fib16 slightly decreased transduction of normal pancreas compared to Ad5 but is still able to transduce normal pancreas. This is not an unexpected finding because immunohistochemical analysis of CD46 expression in human pancreas revealed staining in exocrine ducts, islets of Langerhans and acinar cells. 44 Increased transduction of pancreatic cancer cells in combination with reduced transduction of normal tissue indicates that the fiber-chimeric adenoviruses seem more specific for pancreatic cancer.
Systemic administration will be needed for effective Ad vector-mediated gene therapy in patients with metastasized cancer. Liver tropism is a major issue for systemic application of viral vectors including adenovirus since efficient transduction of the liver can cause liver toxicity. In addition, it will result in loss of a large percentage of injected virus due to which a higher dose will be needed for a therapeutic effect. To study liver tropism, we also determined transduction efficiency of both chimeric vectors on primary hepatocytes. For both chimeric Ad vectors, the transduction efficiency of isolated primary hepatocytes is reduced compared to Ad5. Other groups have already shown that the lower transduction of hepatocytes by group B Ad vectors results in detargeting of the liver upon systemic administration. Biodistribution pattern of group B adenovirus in nonhuman primates revealed lower transduction of the liver. 45 Studies with other fiber-chimeric adenoviruses, such as Ad5 containing fiber 3, also showed decreased liver toxicity due to lower transduction of the liver. 46 The lower expression levels of CD46 on human liver cells may explain the lower transduction by subgroup B adenoviruses of hepatocytes in vitro and the entire liver in vivo. 47 In the United States, Europe and Asia, preexisting immunity against Ad5 exists in approximately 80% of the population. In comparison less than 15% display immunity toward Ad16 and Ad50. 48 Therefore, replacing Ad5 fibers by those of serotype 16 or 50 could decrease preexisting neutralizing immunity toward fiber-chimeric Ad vectors. However, this effect will be limited because the immune response is also directed toward the adenovirus hexon protein, which is part of the Ad capsid. 49 Therefore additional modifications such as replacing the hexon protein of Ad5 by that of a group B serotype seems to be needed to effectively reduce preexisting immunity against the chimeric vectors.
In conclusion, fiber 16 and 50 reveal a significantly enhanced gene transfer and specificity to human pancreatic cancer cell lines and in primary resection specimens. Vectors with increased specificity are needed to expand the therapeutic window of Ad gene therapy for pancreatic cancer. Development of a conditional replicating chimeric Ad vector in this respect seems a promising approach.
